Volta, Francesco
 Distribuzione geografica
Continente #
EU - Europa 208
NA - Nord America 146
AS - Asia 49
AF - Africa 8
Totale 411
Nazione #
US - Stati Uniti d'America 146
IT - Italia 136
IE - Irlanda 30
SG - Singapore 20
CN - Cina 17
SE - Svezia 15
NL - Olanda 10
CI - Costa d'Avorio 8
AT - Austria 3
BE - Belgio 3
DE - Germania 3
JP - Giappone 3
TR - Turchia 3
FI - Finlandia 2
HK - Hong Kong 2
ID - Indonesia 2
CH - Svizzera 1
ES - Italia 1
FR - Francia 1
GB - Regno Unito 1
IN - India 1
KR - Corea 1
PL - Polonia 1
SI - Slovenia 1
Totale 411
Città #
Chandler 33
Dublin 30
Parma 29
Ann Arbor 25
Milan 21
Ashburn 14
Shanghai 14
Amsterdam 10
Chicago 10
Abidjan 8
Boardman 8
Auburn 6
Modena 5
Reggio Emilia 5
Bottanuco 4
Florence 4
New York 4
Salsomaggiore Terme 4
Wayne 4
Alvignano 3
Bologna 3
Istanbul 3
Leuven 3
Neviano degli Arduini 3
Rubiera 3
Verona 3
Bremen 2
Campi Bisenzio 2
Carpenedolo 2
Castellarano 2
Central 2
Chiari 2
Des Moines 2
Fremont 2
Hayamiya 2
Helsinki 2
Los Angeles 2
Maranello 2
Menteng 2
Pavia 2
Prata Di Pordenone 2
Princeton 2
Ravenna 2
Rome 2
Rottofreno 2
Singapore 2
Sondrio 2
Vienna 2
Woodbridge 2
Brescia 1
Casalgrande 1
Castelverde 1
Cesano 1
Council Bluffs 1
Credaro 1
Desio 1
Fairfield 1
Ferrara 1
Gangseo-gu 1
Grafing 1
Houston 1
Innsbruck 1
Kagoya 1
Leawood 1
Ljubljana 1
London 1
Madrid 1
Naples 1
Padova 1
Palermo 1
Paris 1
Piacenza 1
Pune 1
San Jose 1
Sassuolo 1
Sesto San Giovanni 1
St. Moritz 1
Taiyuan 1
Torun 1
Totale 335
Nome #
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 117
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 68
Isolation and characterization of H23 clones resistant to the KRASG12C inhibitors sotorasib and adagrasib 53
Biological hallmarks and new therapeutic approaches for the treatment of pdac 51
PD-L1 OVEREXPRESSION INDUCES ANGIOGENIC CYTOKINE SECRETION AND ENDOTHELIAL CELL MIGRATION VIA STAT SIGNALLING. 49
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 42
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 40
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 7
Totale 427
Categoria #
all - tutte 1.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 6 6 9 0 5 7
2021/202245 7 4 12 0 2 1 3 0 5 0 2 9
2022/2023140 7 7 8 6 9 12 1 27 38 0 16 9
2023/2024186 3 9 12 5 19 22 16 17 7 7 36 33
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 427